BBA
DGX icon

Braun-Bostich & Associates’s Quest Diagnostics DGX Stock Holding History

Braun-Bostich & Associates’s Portfolio DGX Stock Details DGX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q1 		– Sell
-66
Closed -$5K – 329
2018
Q4 		$5K Hold
66
– – 0.01% 281
2018
Q3 		$7K Buy
+66
New +$7.24K 0.01% 278

Other funds holding DGX

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return
FMI
Fiduciary Management Inc Milwaukee, Wisconsin $8.06B AUM 6.78% 1-Year Est. Return
DSA
Davis Selected Advisers Tucson, Arizona $21.8B AUM 23.45% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $95.5B AUM 28.4% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Braun-Bostich & Associates's DGX Position: Q1 2019 in Review

Braun-Bostich & Associates sold out of Quest Diagnostics (DGX) in Q1 2019, closing a stake of 66 shares — an estimated $5K sold.

Braun-Bostich & Associates first reported a position in DGX in Q3 2018 and held it in 2 quarters. The position peaked at $7K in Q3 2018. 656 funds tracked by Wall St. Rank hold DGX as of Q1 2019.

  • Braun-Bostich & Associates reported no remaining Quest Diagnostics position as of Q1 2019 after selling out during the quarter.
  • Braun-Bostich & Associates sold 66 Quest Diagnostics shares in Q1 2019, an estimated $5K.
  • Braun-Bostich & Associates first reported a position in Quest Diagnostics in Q3 2018 and held it in 2 quarters.
  • Braun-Bostich & Associates's Quest Diagnostics position peaked at $7K in Q3 2018.
  • 656 funds tracked by Wall St. Rank held Quest Diagnostics as of Q1 2019.

Based on Braun-Bostich & Associates's 13F filing for Q1 2019, filed 9 May 2019.